Brazil Cardiac Pacemakers Market, by Product Type (Implantable Cardiac Pacemaker, External Cardiac Pacemaker) by Technology (Single Chamber Pacemaker, Dual Chamber Pacemaker, Biventricular Pacemaker), by End Users (Hospitals, Ambulatory Surgery enters, Cardiac Clinics), is estimated to be valued at US$ 305 in 2021 and is expected to exhibit a CAGR of 2.4% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Key players operating in the market are focusing on receiving product approvals from regulatory authorities and this is expected to drive the market growth over the forecast period.
For instance, in March 2017, the U.S. Centres for Medicare & Medicaid Services (CMS) approved medical coverage for Micra Transcatheter Pacing System (a miniaturized single chamber pacemaker that is inserted directly into the right ventricle) (TPS). This approval follows successful completion of two studies, which enables reimbursement through Medicare's policy of Coverage with Evidence Development (CED)
Brazil Cardiac Pacemakers Market – Impact of Coronavirus (Covid-19) Pandemic
COVID-19 outbreak was first reported on December 31, 2019 in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 193 million cases and 4.1 million deaths due to Coronavirus (COVID-19) were reported up till July 25, 2021 across the globe.
For instance, according to National Library of Medicine, average of 33.1 pacemakers were inserted per month in the BC period; and only nine pacemakers were inserted per month during the COVID period.
Furthermore, in pre-social isolation period, no evidence of variation was noticed as compared to previous years. Moreover, compared to the relative 2019 period, there was a slight increase in the number of patients in post-lockdown and more number of patients presented with bradycardia.
Browse 12 Market Data Tables and 14 Figures spread through 123 Pages and in-depth TOC on “Brazil Cardiac Pacemakers Market”- Forecast to 2028, by Product Type (Implantable Cardiac Pacemaker, External Cardiac Pacemaker) by Technology (Single Chamber Pacemaker, Dual Chamber Pacemaker, Biventricular Pacemaker), by End Users (Hospitals, Ambulatory Surgery Centres, Cardiac Clinics)
To know the latest trends and insights prevalent in the Brazil Cardiac Pacemakers Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/brazil-cardiac-pacemakers-market-4865
Key players operating in the market are focusing on adoption of inorganic growth strategies such as mergers, collaborations, partnerships, and acquisitions, in order to strengthen their position in the global market. For instance, Livanova Plc. has a wide portfolio of pacemakers and offers products around 100 countries. The company has built strong presence in different regions with the acquisitions of regional companies. Moreover, the company acquired Brazil-based Alcard Industria Mecanica Ltda. to strengthen its presence in Brazil market.
Key Takeaways of the Brazil Cardiac Pacemakers Market
- The Brazil Cardiac Pacemakers Market is expected to exhibit a CAGR of 2.4% over the forecast period, owing to rising launches and regulatory approvals of products. For instance, in April 2021, Medtronic plc. Partnered with cyber security startup Sternum to protect its pacemakers from hackers. The partnership with Sternum is fixed for a long term. Medtronic has now protected 100,000 of its devices, with the help of Israel-based Cybersecurity supplier.
- Among product type, Implantable Cardiac Pacemaker is expected to account for the largest market share during the forecast period. For instance, as per the data published by Sociedade Brasileira De Cardiologia (SBC), around 25-30% of cardiac stimulation are performed for Chagas disease in Brazil.
- Major players operating in the Brazil cardiac pacemakers market include BIOTRONIK SE & Co.KG, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova plc., Osypka Medical GmbH, MEDICO S.p.A.
